Ipilimumab is a prescription medication used to treat melanoma (a type of skin cancer). Ipilimumab belongs to a group of drugs called monoclonal antibodies, which help slow or stop the growth of cancer cells.
This medication comes in an injectable form to be given directly into a vein (IV) by a healthcare provider, once every 3 weeks for up to 4 doses.
Common side effects include tiredness, diarrhea, and itching.